Toxic epidermal necrolysis associated with combination therapy of spironolactone and torsemide

Journal Title: Journal of Pharmacovigilance and Drug Research - Year 2020, Vol 1, Issue 20201105

Abstract

Dytor plus tablet is a fixed-dose combination of torsemide and spironolactone used for generalized edema. TEN is a serious, potentially life-threatening dermatological disorder. Here we present a case report of a 47-year-old female who was on Dytor Plus (5/50 mg)therapy once daily for generalized edema; presented to dermatology outpatient department with chief complaints of multiple erosions over oral cavity, swelling of lips with scaling, redness and burning sensation in both eyes, multiple well defined mostly erythematous rashes over the entire body since 2 days .on examination, her vital signs were stable and lab result indicate she had elevated SGOT(140 IU/L), SGPT (228 IU/L), ALP (162IU/L) and blood urea(47 mg/ml) values. The patient was diagnosed to have developed Dytor plus induced toxic epidermal necrolysis. Discontinued the medicine and prescribed with Dexamethasone injection, IgG Injection, Cefotaxime injection, Cloxacilline capsule, Cetirizine tablet, Hydroxypropyl methylcellulose eye drop, and candid mouth paint. The patient had a hospital stay of 25 days. The patient improved symptomatically. Causality was assessed as per the WHO-UMC causality scale and this case was put in the probable category. This case was uploaded via vigiflow under the pharmacovigilance programme of India having report Id 2019-30695.

Authors and Affiliations

Melcy Mary Philip 1*, Kala Kesavan P 1, Jai Prakash 2

Keywords

Related Articles

Risk-benefit associated with Azithromycin: A brief review

Azithromycin is the most popular prescribed antimicrobial agent around the world. It comes under the class of macrolide antibiotics. Because of its higher efficacy, tolerance, and broad-spectrum activity, it is primarily...

Overview of important methods used for Causality Assessment of adverse drug events in Pharmacovigilance

The method of assessing causality between adverse events and suspect drugs is the most challenging task in pharmacovigilance. It requires attentive consideration of both the adverse events and suspect drugs, patient-rela...

Metformin related adverse events: A prospective observational study in health care centers of western Odisha

The study was done to explore the management of the patients having diabetes by primary care physicians, and the adverse reactions associated with the dose regimens. A qualitative In-Depth Interview study was conducted a...

Toxic epidermal necrolysis associated with combination therapy of spironolactone and torsemide

Dytor plus tablet is a fixed-dose combination of torsemide and spironolactone used for generalized edema. TEN is a serious, potentially life-threatening dermatological disorder. Here we present a case report of a 47-year...

Nevirapine induced Stevens Johnson Syndrome

A 56-year-old male patient presented with a complaint of lesions all over the body with a burning sensation for 4 days. He was on an ART regimen, containing zidovudine, lamivudine, and efavirenz combination for 4 years....

Download PDF file
  • EP ID EP690855
  • DOI 10.5281/zenodo.4016769
  • Views 189
  • Downloads 0

How To Cite

Melcy Mary Philip 1*, Kala Kesavan P 1, Jai Prakash 2 (2020). Toxic epidermal necrolysis associated with combination therapy of spironolactone and torsemide. Journal of Pharmacovigilance and Drug Research, 1(20201105), -. https://europub.co.uk/articles/-A-690855